Eroom's Law: The Exponential Cost of Drug Discovery

Technology generally becomes faster and cheaper over time. Computers follow Moore's Law, doubling in power while halving in price. Yet, in the realm of life-saving medicine, the exact opposite is happening. "Eroom's Law" (Moore spelled backward) highlights a terrifying economic reality: the cost of discovering and developing a new drug doubles roughly every nine years. Despite massive advancements in artificial intelligence, genome sequencing, and automated chemical screening, the pharmaceutical industry is suffering from crippling stagnation. The hidden bottlenecks are not scientific, but systemic. Hyper-cautious regulatory environments, the exhaustion of "low-hanging fruit" in basic biology, and the astronomical financial burden of late-stage clinical trials have ground innovation to a halt. This text meticulously deconstructs the multi-billion-dollar gamble of modern pharmacology. You will trace the logistical hurdles of bringing a single molecule to market, the corporate strategy of acquiring smaller biotech startups rather than innovating, and the systemic inefficiencies threatening the future of global healthcare. Step inside the boardrooms of the medical industry. Understand the brutal economic math that dictates which diseases get cured and why the golden age of drug discovery may be behind us.